NasdaqGS - Nasdaq Real Time Price USD
Ventyx Biosciences, Inc. (VTYX)
1.3050
+0.1350
+(11.54%)
As of 2:46:08 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 7 | 6 |
| Avg. Estimate | -0.55 | -0.59 | -2.06 | -1.93 |
| Low Estimate | -0.57 | -0.61 | -2.38 | -2.26 |
| High Estimate | -0.53 | -0.57 | -1.88 | -1.63 |
| Year Ago EPS | -0.45 | -0.5 | -1.97 | -2.06 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | 15.28M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 91.71M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.57 | -0.51 | -0.55 | -0.48 |
| EPS Actual | -0.45 | -0.5 | -0.41 | -0.39 |
| Difference | 0.12 | 0.01 | 0.14 | 0.09 |
| Surprise % | 21.64% | 1.96% | 24.87% | 19.03% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.55 | -0.59 | -2.06 | -1.93 |
| 7 Days Ago | -0.51 | -0.55 | -2.06 | -1.93 |
| 30 Days Ago | -0.51 | -0.55 | -2.01 | -1.84 |
| 60 Days Ago | -0.51 | -0.55 | -2.01 | -1.84 |
| 90 Days Ago | -0.59 | -0.62 | -2.17 | -1.94 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 4 | 2 |
| Up Last 30 Days | 1 | 1 | 4 | 2 |
| Down Last 7 Days | -- | -- | 2 | 2 |
| Down Last 30 Days | -- | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VTYX | -21.48% | -17.33% | -4.42% | 5.94% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 1/14/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 11/11/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 11/8/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 10/15/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 9/23/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 8/12/2024 |
Related Tickers
HLVX HilleVax, Inc.
1.9050
-0.26%
EPIX ESSA Pharma Inc.
1.7100
0.00%
KZR Kezar Life Sciences, Inc.
4.2500
+3.16%
ASMB Assembly Biosciences, Inc.
12.30
+5.45%
ANTX AN2 Therapeutics, Inc.
1.1750
-3.69%
KROS Keros Therapeutics, Inc.
13.78
-1.71%
SPRO Spero Therapeutics, Inc.
0.6399
+11.29%
IPSC Century Therapeutics, Inc.
0.5298
+1.88%
CLRB Cellectar Biosciences, Inc.
0.2484
-1.23%
RPTX Repare Therapeutics Inc.
1.3550
-0.37%